Washington tax hike quietly slashes cancer-research cash, warns GOP Senator
Washington’s recent sales-tax expansion will redirect vape-product revenue away from the state’s cancer-research fund, warns Sen. John Braun of Centralia.
A Democrat-passed sales tax comes with significant implications for cancer research. (Photo by Michael M. Santiago/Getty Images)
(Photo by Michael M. Santiago/Getty Images)
Republican State Senator Majority Leader John Braun (R-Centralia) contends that state legislators’ decision to broaden the sales tax is inadvertently undermining funding for cancer research in Washington.
In commentary published in The Chronicle, Braun argues that when the expansion of the sales tax takes effect Jan. 1, especially the portion applying to nicotine and vapor products, revenue that previously went to the Andy Hill Cancer Research Endowment Fund (CARE Fund) will instead flow into the state’s general fund. The CARE Fund was established in 2015 and is tied to tax revenue from vapor product sales and other tobacco-derived nicotine products. By law, the state matches up to $10 million annually in those funds.
“Starting Jan. 1 … tax revenue from the sales of vapor products containing nicotine will stop going into the Andy Hill CARE fund. It will go into the general fund instead,” he wrote.
According to Braun, the legislation passed this year via Senate Bill 5814 expands the definition of taxable “nicotine, whether derived from tobacco or created synthetically,” and under the interpretation of the Washington State Department of Revenue (DOR), vapor products with nicotine now fall under the higher tax rate.
A warning on cancer research funding
Braun warns that the tax revenue from nicotine-containing vapor products effectively shrinks the amount available for cancer research grants. He also notes that because fewer dollars will arrive, state matching funds will shrink accordingly.
“There just wasn’t time for anyone on the outside to thoroughly scrutinize the nicotine tax part of the bill before its passage,” he wrote.
The senator also places responsibility on the majority-Democrat legislature and the governor’s budget office and tax agency for what he describes as a “fiasco.” If unaddressed, cancer-research advocates say the shift could reduce grant availability in Washington just as funding opportunities tighten nationally.
Follow Seattle Red on-air at 770 AM, on the Seattle Red app, and streaming audio and video on SeattleRed.com.






Comments
1 Comments
Didn't you know? This is all Trump's fault! Just ask any of the democrats who voted to do this!